Marshall Wace’s St Jude Medical STJ Stock Holding History

Marshall Wace’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-668,559	Closed	-$53.6M	–	981
2016 Q4	$53.6M	Sell	668,559 -513,036	-43%	-$40.7M	0.35%	69
2016 Q3	$94.2M	Buy	+1,181,595	New	+$95.4M	0.67%	27
2016 Q1	–	Sell	-286,788	Closed	-$17.7M	–	1313
2015 Q4	$17.7M	Buy	286,788 +229,078	+397%	+$14.4M	0.17%	148
2015 Q3	$3.64M	Buy	57,710 +51,533	+834%	+$3.68M	0.04%	345
2015 Q2	$452K	Buy	+6,177	New	+$446K	0.01%	731
2015 Q1	–	Sell	-70,180	Closed	-$4.56M	–	1026
2014 Q4	$4.56M	Buy	+70,180	New	+$4.52M	0.06%	324

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Marshall Wace's STJ Position: Q1 2017 in Review

Marshall Wace sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 668,559 shares — an estimated $53.6M sold.

Marshall Wace first reported a position in STJ in Q4 2014 and held it in 6 quarters. The position peaked at $94.2M in Q3 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

Marshall Wace reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
Marshall Wace sold 668,559 St Jude Medical shares in Q1 2017, an estimated $53.6M.
Marshall Wace first reported a position in St Jude Medical in Q4 2014 and held it in 6 quarters.
Marshall Wace's St Jude Medical position peaked at $94.2M in Q3 2016.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Marshall Wace's 13F filing for Q1 2017, filed 12 May 2017.